A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Authors
Keywords
-
Journal
European Heart Journal-Cardiovascular Pharmacotherapy
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-06-04
DOI
10.1093/ehjcvp/pvaa064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Outbreak of a novel coronavirus
- (2020) Andrea Du Toit NATURE REVIEWS MICROBIOLOGY
- COVID-19 with Different Severities: A Multicenter Study of Clinical Features
- (2020) Yun Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence
- (2020) Krishna Sriram et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
- (2020) Gianluca Trifirò et al. DRUG SAFETY
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
- (2020) Juan Simon Rico-Mesa et al. Current Cardiology Reports
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started